Steris PLC (STE)
223.94
+3.27
(+1.48%)
USD |
NYSE |
Sep 22, 16:00
223.96
+0.02
(+0.01%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 22.12B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 27.93% |
| Valuation | |
| PE Ratio | 183.56 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.410 |
| Price to Book Value | 3.586 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.52 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.474 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.17% |
Profile
| Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions. |
| URL | https://www.steris-ir.com |
| Investor Relations URL | https://sterisplc.gcs-web.com |
| HQ State/Province | Ohio |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Nov. 09, 2023 (est.) |
| Last Earnings Release | Aug. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 05, 2023 |
Ratings
Profile
| Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions. |
| URL | https://www.steris-ir.com |
| Investor Relations URL | https://sterisplc.gcs-web.com |
| HQ State/Province | Ohio |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Nov. 09, 2023 (est.) |
| Last Earnings Release | Aug. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 05, 2023 |